Market Overview

UPDATE: Compass Point Upgrades DR Horton to Neutral on Updated Forecasts

Related DHI
Hombuilders Trending Lower Following Housing Starts, Building Permits Readings
Homebuilder Confidence Dips, Sector Stocks Follow
Making Money With Charles Payne: 11/13/14 (Fox Business)

Compass Point raised its rating on DR Horton (NYSE: DHI) from Sell to Neutral and raised its price target to $18.50.

Compass Point commented, "After a full model update we are raising estimates and, coupled with the stock's relative underperformance in the post-QE3 trade, we now feel DHI should perform in line with the rest of the space. Our price target increase reflects our increased 2013 EPS estimate to $0.93 from $0.87 as well as a consistent 5% assumed ROI. We still see downside in the shares to $18 but the stock is off 12% since the Fed announced QE3 in early September and has been the second worst performer in the homebuilding sector over that time frame."

DR Horton closed at $19.58 on Wednesday.

Latest Ratings for DHI

DateFirmActionFromTo
Nov 2014Compass PointReiteratesBuy
Nov 2014Keefe Bruyette & WoodsMaintainsMarket Perform
Nov 2014Credit SuisseMaintainsNeutral

View More Analyst Ratings for DHI
View the Latest Analyst Ratings

Posted-In: Compass PointAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (DHI)

Around the Web, We're Loving...

Get Benzinga's Newsletters